L, F., JA, N., R, S., K, E., ME, G., & J, L. (2013). Second primary melanomas on treatment with vemurafenib: Reply from the authors. The British journal of dermatology, 168(4), 888. https://doi.org/10.1111/bjd.12094
Chicago Style (17th ed.) CitationL, Fearfield, Newton-Bishop JA, Sinha R, Edmonds K, Gore ME, and Larkin J. "Second Primary Melanomas on Treatment with Vemurafenib: Reply from the Authors." The British Journal of Dermatology 168, no. 4 (2013): 888. https://doi.org/10.1111/bjd.12094.
MLA (9th ed.) CitationL, Fearfield, et al. "Second Primary Melanomas on Treatment with Vemurafenib: Reply from the Authors." The British Journal of Dermatology, vol. 168, no. 4, 2013, p. 888, https://doi.org/10.1111/bjd.12094.
Warning: These citations may not always be 100% accurate.